Remodeling of the liver fibrosis microenvironment based on nilotinib-loaded multicatalytic nanozymes with boosted antifibrogenic activity

Liver fibrosis is a reversible pathological process caused by chronic liver damage and a major risk factor for hepatocellular carcinoma (HCC). Hepatic stellate cell (HSC) activation is considered the main target for liver fibrosis therapy. However, the efficiency of this strategy is limited due to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Huaqing, Ren, Yingzi, Zhou, Yue, Xu, Min, Krizkova, Sona, Heger, Zbynek, Lu, Qiang, Wang, Siyu, Liang, Xiaoyang, Adam, Vojtech, Li, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692490/
https://www.ncbi.nlm.nih.gov/pubmed/38045041
http://dx.doi.org/10.1016/j.apsb.2023.08.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692490/
https://www.ncbi.nlm.nih.gov/pubmed/38045041
http://dx.doi.org/10.1016/j.apsb.2023.08.020

Ejemplares similares